Enzo Biochem Unit Launches First-to-Market Survival Motor Neuron (SMN) Protein Immunoassay System
March 15, 2011
FARMINGDALE, N.Y. & NEW YORK - Enzo Biochem, Inc. and the Spinal Muscular Atrophy (SMA) Foundation today announced that Enzo’s wholly owned subsidiary, Enzo Life Sciences Inc., has launched a unique immunoassay (ELISA) system which can be used for the identification and detection of Survival Motor Neuron (SMN) protein. The kit is the result of [...]
March 15, 2011
FOSTER CITY, Calif. - AB SCIEX, a global leader in life science analytical technologies, and Alturas Analytics Inc., a leading provider of LC/MS contract research services for the pharmaceutical and biotech industries, today announced a collaboration to accelerate the adoption of dried blood spot (DBS) analysis for drug discovery & development. This analysis is designed [...]
Fluidigm Adds Patrick Jones to Its Board of Directors
March 15, 2011
SOUTH SAN FRANCISCO, Calif. - Fluidigm Corporation (NASDAQ:FLDM) today announced that Patrick S. Jones has been appointed to Fluidigm’s Board of Directors. Mr. Jones fills the vacancy created by the resignation of Jeremy Loh, which was effective on March 10, 2011. Mr. Jones will also join and chair the Board’s audit committee. “We are excited [...]
March 15, 2011
FOSTER CITY, Calif. - To address the global need for improved methods in toxicology, food safety testing and environmental analysis, AB SCIEX, a global leader in life science analytical technologies, today announced the expansion of its iMethod™ Application Center. This online resource provides a growing library of pre-configured, verified test methods to improve the analysis [...]
Exiqon Releases Additional 235 Pre-Validated qPCR Assays for Mouse and Rat microRNAs
March 15, 2011
COPENHAGEN, Denmark - Exiqon A/S (Copenhagen:EXQ - News), a leading supplier of high-value gene expression analysis products, today announced the launch of additional 235 pre-validated miRCURY LNATM Universal RT microRNA qPCR assays for sensitive and specific quantification of microRNAs. With the launch of the new assays, Exiqon now offers 1731 pre-validated qPCR assays for human, [...]
MBL Signs Non-Exclusive License With Envoy Therapeutics for Access to RIP-Chip Technology
March 15, 2011
WOBURN, Mass. - Medical & Biological Laboratories Co., Ltd., MBL, has signed a non-exclusive license with Envoy Therapeutics for access to MBL's patented RIP-Chip technology. As part of the license agreement, MBL will receive upfront payment, annual licensing fees and potential milestone payments. Envoy Therapeutics will utilize the RIP-Chip technology for the company's drug discovery [...]
March 15, 2011
Berlin - JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the work from the Light Technology Institute at the Karlsruhe Institute of Technology (KIT) in Germany where the JPK NanoWizard® family of AFMs provide the backbone for topographic and optical research activities. The generation and [...]
DNA2.0 Expands to New Menlo Park Facility
March 15, 2011
Menlo Park, CA - DNA2.0, the leading gene synthesis and protein engineering company, announced today that it has moved to a new, state-of-the-art facility in the heart of Silicon Valley and the Menlo Park technology corridor. DNA2.0 chose the 23,000 square foot space to accommodate the company’s rapid growth—especially in the development of gene design [...]
March 15, 2011
SAN FRANCISCO - At the Cleantech Forum in San Francisco today and as part of its recently launched Veolia Innovation Accelerator (VIA) program, Veolia Environnement announced the first partnerships signed with some of the most innovative startups in the cleantech sector. Among these partnerships: Envolure, a French startup specializing in the design and marketing of [...]
March 14, 2011
Atlanta, Georgia - Waters Corporation (WAT:NYSE) today unveiled three new Waters® ACQUITY UPLC® Systems further extending the impact of sub-two micron separation technology to address targeted analytical challenges. The addition of the Waters ACQUITY UltraPerformance Supercritical Fluid Chromatography (UPSFC™) System, the ACQUITY® UPLC System with 2D Technology, and the Patrol UPLC® Laboratory Analyzer further reinforces [...]